<DOC>
	<DOCNO>NCT02424786</DOCNO>
	<brief_summary>The study aim investigate adherence polypharmacy elderly patient chronic kidney disease ( CKD ) End Stage Renal Disease ( ESRD ) . The investigator look possible factor predictor may affect adherence reduce polypharmacy . Factors could : quality life , anxiety depression , beliefs medicine cognitive impairment . The investigator plan intervention screen tool Screening Tool Older Person 's potentially inappropriate Prescription/Screening tool Alert Right Treatment ( STOPP/START ) criteria evaluate medication list participate patient .</brief_summary>
	<brief_title>Non-adherence Polypharmacy Elderly Patients</brief_title>
	<detailed_description>The investigator intend include patient &gt; 65 year old , dialysis treatment ( hemodialysis peritoneal dialysis ) , well patient CKD stage 5 . The recruitment do follow : The patient screen accord inclusion criterion . Afterwards patient invite first meeting explains aim study , give opportunity discussion consideration , present consent information . After give consent patient invite second meeting blood test , data registration , medication registration , undergo MMS hand questionnaire form . Randomization : After initial assessment compliance eligibility criterion , participant randomize intervention group ( medication list evaluate STOPP/START criterion ) control group ( medication list evaluate STOPP/START criterion ) . Randomization number generate random number generator . A series number , seal , opaque envelope use ensure confidentiality . Each envelope contain card information group allocation . The group allocation conceal researcher patient baseline registration . Each patient get questionnaire : Quality life use Kidney Disease Quality Life - Short form 36 ( KDQOL-Short form 36 ) EuroQoL-3D ( EQ-3D ) , beliefs medicine , Hospital Anxiety Depression Scale ( HADS ) , Morisky medication adherence scale visual adherence scale ( VAS ) , sleep related questionnaire ( Epworth , Berlin , Pittsburgh ) . A Mini Mental Status ( MMS ) test do regard cognitive function . Each patient get opportunity polysomnograph one night . With STOPP/START criterion medication list evaluate patient randomize intervention group .</detailed_description>
	<criteria>All patient &gt; 65 year CKD , stage 5 ( eGFR â‰¤ 12 ml/min ) , undergo treatment hemodialysis peritoneal dialysis Patients willing participate Patients diagnose dementia severe cognitive disorder ( MMS &lt; 25 ) , Patients hear impairment Patients language difficulty</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Adherence</keyword>
	<keyword>Polypharmacy</keyword>
	<keyword>Elderly</keyword>
	<keyword>Chronic kidney disease</keyword>
</DOC>